Bionomics Historical Cash Flow
| BNOX Stock | USD 0.30 0.02 7.14% |
Analysis of Bionomics cash flow over time is an excellent tool to project Bionomics ADR future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 14.2 M or Depreciation of 1 M as it is a great indicator of Bionomics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Bionomics ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bionomics ADR is a good buy for the upcoming year.
Bionomics |
About Bionomics Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Bionomics balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Bionomics's non-liquid assets can be easily converted into cash.
Bionomics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Bionomics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Bionomics ADR current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. At this time, Bionomics' Total Cashflows From Investing Activities is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 7.7 M in 2024, despite the fact that Free Cash Flow is likely to grow to (13.9 M).
Bionomics cash flow statement Correlations
Click cells to compare fundamentals
Bionomics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bionomics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (9.4M) | 23.9M | 1.8M | (11.0M) | 505.0K | 694.2K | |
| Free Cash Flow | (3.9M) | (7.5M) | (15.0M) | (14.2M) | (14.7M) | (13.9M) | |
| Begin Period Cash Flow | 14.0M | 4.6M | 21.4M | 23.2M | 12.2M | 14.2M | |
| Depreciation | 2.2M | 1.7M | 766.0K | 770.6K | 663.0K | 1.0M | |
| Other Non Cash Items | 7.1M | 8.7M | (2.6M) | 5.1M | 137.1M | 143.9M | |
| Capital Expenditures | 69.5K | 7.7K | 1.5K | 1.1K | 4.44 | 4.22 | |
| Total Cash From Operating Activities | (3.9M) | (7.5M) | (15.0M) | (14.2M) | (14.7M) | (13.9M) | |
| Net Income | (5.8M) | (8.7M) | (15.0M) | (21.2M) | (15.5M) | (14.7M) | |
| Total Cash From Financing Activities | (5.4M) | 31.6M | 18.6M | 3.7M | 15.1M | 8.2M | |
| End Period Cash Flow | 4.6M | 28.5M | 23.2M | 12.2M | 12.7M | 15.1M | |
| Other Cashflows From Financing Activities | (329.9K) | (415.5K) | (6.9M) | (2.5M) | 5.0M | 5.2M | |
| Change To Inventory | (28.3K) | 152.8K | 3.9M | (4.8M) | (4.3M) | (4.1M) | |
| Stock Based Compensation | 55.4K | 1.3M | 2.8M | 1.9M | 814.8K | 980.5K | |
| Change In Working Capital | 4.0M | 1.6M | (27.0K) | 33.1K | 1.5M | 864.7K | |
| Change To Account Receivables | (202.3K) | 34.1K | (27.0K) | 33.1K | 196.1K | 205.9K | |
| Net Borrowings | (8.3M) | (11.9M) | (174.2K) | (160.0K) | (144.0K) | (151.2K) | |
| Total Cashflows From Investing Activities | (195.1K) | (80.2K) | 621.7K | 479.5K | 551.5K | 579.0K | |
| Change To Operating Activities | 4.4M | 1.8M | (6.4M) | 6.4M | 7.4M | 7.7M | |
| Other Cashflows From Investing Activities | (949.6K) | 4.1K | 12.5K | 479.5K | 431.6K | 453.2K | |
| Change To Netincome | (3.0M) | (2.4M) | 4.5M | 2.4M | 2.7M | 2.9M | |
| Change To Liabilities | (121.1K) | (250.7K) | 788.1K | 507.4K | 583.5K | 612.7K | |
| Issuance Of Capital Stock | 2.2M | 32.9M | 32.9M | 7.4M | 10.1M | 17.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.